Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial

被引：0
|
作者：
Unagami, Kohei [1 ]
Okumi, Masayoshi [2 ]
Furusawa, Miyuki [2 ]
Hirai, Toshihito [2 ]
Omoto, Kazuya [2 ]
Shimizu, Tomokazu [2 ]
Inui, Masashi [2 ]
Ishida, Hideki [2 ]
Tanabe, Kazunari [2 ]
Nitta, Kosaku [1 ]
机构：
[1] Tokyo Womens Med Univ, Nephrol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Urol, Tokyo, Japan
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.1511
引用
收藏
页码：S713 / S714
页数：2
相关论文
共 50 条
  • [21] Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
    Thorat, Ashok
    Chou, Hong-Shiue
    Lee, Chen-Fang
    Soong, Ruey-Shyang
    Wu, Tsung-Han
    Cheng, Chih-Hsien
    Wu, Ting-Jung
    Chan, Kun-Ming
    Lee, Wei-Chen
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [22] Conversion from Tacrolimus or Ciclosporine twice-daily to Tacrolimus once-daily in adolescents after pediatric liver transplantation
    Weil, T.
    Debray, D.
    Kramer, L.
    Habes, D.
    Taburet, A. -M.
    Furlan, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 144 - 144
  • [23] Once-Daily Extended-Release Formulation of Tacrolimus Does Not Require Double Dose of Twice-Daily Formulation of Tacrolimus in Kidney Transplantation.
    Harada, H.
    Fukuzawa, N.
    Hotta, K.
    Seki, T.
    Togashi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 315 - 315
  • [24] Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome
    Sforza, D.
    Laria, G.
    Petagna, L.
    Parente, A.
    Anselmo, A.
    Sergi, F.
    Marzio, S.
    Corrado, F.
    Telli, S.
    Manzia, T. M.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (01) : 140 - 142
  • [25] Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial
    Okumi, Masayoshi
    Unagami, Kohei
    Furusawa, Miyuki
    Kakuta, Yoichi
    IIzuka, Junpei
    Takagi, Toshio
    Shirakawa, Hiroki
    Shimizu, Tomokazu
    Omoto, Kazuya
    Inui, Masashi
    Ishida, Hideki
    Tanabe, Kazunari
    CLINICAL TRANSPLANTATION, 2018, 32 (12)
  • [26] FIVE-YEAR BUDGET IMPACT ANALYSIS OF ONCE-DAILY VERSUS TWICE-DAILY TACROLIMUS, IN PATIENTS UNDERGOING RENAL TRANSPLANT IN THE UNITED KINGDOM
    Sidhu, M.
    Lees, L.
    Warner, J.
    VALUE IN HEALTH, 2010, 13 (03) : A77 - A77
  • [27] Comparison of Pharmacokinetics of Once- and Twice-Daily Tacrolimus in Pediatric Kidney Transplant Recipients
    Shishido, S.
    Hyoudo, Y.
    Nihei, H.
    Hamasaki, Y.
    Muramatsu, M.
    Niitsu, Y.
    Kawamura, T.
    Sakai, K.
    Aikawa, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 552 - 552
  • [28] Conversion From Twice-Daily to Once-Daily Tacrolimus in Simultaneous Pancreas-Kidney Transplant Patients
    Falconer, S. J.
    Jansen, C.
    Oniscu, G. C.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1458 - 1462
  • [29] Pharmacokinetics for Once-Daily Versus Twice-Daily Tacrolimus Formulations in De Novo Liver Transplantation: A Randomized, Open-Label Trial
    Fischer, Lutz
    Trunecka, Pavel
    Gridelli, Bruno
    Roy, Andre
    Vitale, Alessandro
    Valdivieso, Andres
    Varo, Evaristo
    Seehofer, Daniel
    Lynch, Stephen
    Samuel, Didier
    Ericzon, Bo-Goran
    Boudjema, Karim
    Karpf, Carmen
    Undre, Nasrullah
    LIVER TRANSPLANTATION, 2011, 17 (02) : 167 - 177
  • [30] Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study
    Dopazo, Cristina
    Rodriguez, Roberto
    Llado, Laura
    Calatayud, David
    Castells, Lluis
    Ramos, Emilio
    Molina, Victor
    Garcia, Raquel
    Fabregat, Joan
    Charco, Ramon
    CLINICAL TRANSPLANTATION, 2012, 26 (01) : E32 - E37
12345